PD-1 blockade employed at the time CD8+ T cells are activated enhances their antitumor efficacy

Background We have previously shown that immune checkpoint receptors, including PD-1, are upregulated on T cells at the time of their activation, and that blockade of these receptors can improve the efficacy of antitumor vaccines. In the present study, we sought to determine whether, and by what mec...

Full description

Saved in:
Bibliographic Details
Main Authors: Douglas G McNeel, Donghwan Jeon, Ichwaku Rastogi, Jena E Moseman
Format: Article
Language:English
Published: BMJ Publishing Group 2025-05-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/13/5/e011145.full
Tags: Add Tag
No Tags, Be the first to tag this record!